Innovation, inclusion, and urgency define Kigali HIV conference ANALYSIS | RONALD MUSOKE | When the 13th International AIDS Society (IAS) Conference on HIV Science (IAS 2025) concluded in Kigali after five dynamic days (July 13–17), delegates left with a mix of hope and concern—buoyed by scientific breakthroughs but unsettled by a deepening …
Read More »HIV prevention: Daily oral versus long-acting injectables
Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV. In 2012, the U.S. Food and Drugs Authority (FDA) had first approved Pre-Exposure Prophylaxis (PrEP) daily oral medicines for HIV prevention. More recently, long-acting injectable options of PrEP are also approved. …
Read More »Scorecard: Is Africa on track to meet UNAIDS HIV prevention targets by 2025?
With only three years left to achieve the global testing and treatment targets, African countries are demonstrating significant progress toward HIV epidemic control. Harare, Zimbabwe | BIRD AGENCY | To achieve the 2030 global goal of ending AIDS, the Joint United Nations Programme on HIV/AIDS (UNAIDS) tasked countries to ensure …
Read More »Fighting HIV/AIDS
Uganda’s tough choice between prevention and treatment Kampala, Uganda | FLAVIA NASSAKA | Uganda will in 2019 launch two researches aimed at preventing the spread of HIV/AIDS. The first, dubbed ‘Deliver’,will be based on ring laced with the HIV drug Dapivirinebeing placed in the vagina and an oral drugTruvadataken daily …
Read More »Three decades on, stigma still stymies HIV prevention and treatment
Kampala, Uganda | LINDA-GAIL BEKKER | There have been great strides and many important victories in the fight against HIV. Scientific innovations and sustained investment have been the most important weapons in this ongoing battle. Nevertheless the epidemic retains a powerful grip – especially on people in Africa. In sub-Saharan Africa, 19.4 …
Read More »